AstraZeneca Genomics on AWS: A Journey from Petabytes to New Medicines

2020

AstraZeneca discovers, develops, and commercializes prescription medicines in oncology and biopharmaceuticals, including in cardiovascular, respiratory, and immunology fields. AstraZeneca has a mission to analyze 2 million genomes/exomes by 2026 for integration with clinical data and use in research and development (R&D), clinical trials, and stratified medicine. Using Amazon Web Services (AWS), AstraZeneca built a genomics pipeline using high performance computing services such as AWS Batch and AWS Step Functions, processing more than 1,600 exomes per hour. 

To learn more, watch the video below and visit aws.amazon.com/health.

AWS re:Invent 2020 | AstraZeneca Genomics on AWS: A Journey from Petabytes to New Medicines

Get Started

Companies of all sizes across all industries are transforming their businesses every day using AWS. Contact our experts and start your own AWS Cloud journey today.